TGF-β inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: A dominant role for Smad-2

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 10, 2012, Pages 1608-1616

  Michael, Daryn R ^a   Salter, Rebecca C ^a   Ramji, Dipak P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol; Foam cell; Macrophage; TGF

Indexed keywords

CD36 ANTIGEN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR A; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; FOAM CELL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ANTIGENS, CD36; CELLS, CULTURED; CHOLESTEROL; FOAM CELLS; GENE EXPRESSION; HOMEOSTASIS; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MACROPHAGES; PHOSPHORYLATION; SCAVENGER RECEPTORS, CLASS A; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864367080     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.06.002     Document Type: Article

References (51)

1. McLaren J.E., Michael D.R., Ashlin T.G., Ramji D.P. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog. Lipid Res. 2011, 50:331-347.
2. McLaren J., Michael D., Salter R., Ashlin T., Calder C., Miller A., Liew F., Ramji D. IL-33 reduces macrophage foam cell formation. J. Immunol. 2010, 185:1222-1229.
3. McLaren J., Calder C., McSharry B., Sexton K., Salter R., Singh N., Wilkinson G., Wang E., Ramji D. The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J. Immunol. 2010, 184:5827-5834.
4. McLaren J., Ramji D. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev. 2009, 20:125-135.
5. Singh N., Ramji D. Transforming growth factor-beta-induced expression of the apolipoprotein E gene requires c-Jun N-terminal kinase, p38 kinase, and casein kinase 2. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1323-1329.
6. Singh N., Ramji D. The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev. 2006, 17:487-499.
7. Borkowski P., Robinson M., Kusiak J., Borkowski A., Brathwaite C., Mergner W. Studies on TGF-beta 1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions. Mod. Pathol. 1995, 8:478-482.
8. Shull M., Ormsby I., Kier A., Pawlowski S., Diebold R., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
9. Mallat Z., Gojova A., Marchiol-Fournigault C., Esposito B., Kamaté C., Merval R., Fradelizi D., Tedgui A. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 2001, 89:930-934.
10. Robertson A., Rudling M., Zhou X., Gorelik L., Flavell R., Hansson G. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 2003, 112:1342-1350.
11. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 2008, 7:365-375.
12. Moore K., Freeman M. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1702-1711.
13. Hu Y.W., Wang Q., Ma X., Li X.X., Liu X.H., Xiao J., Liao D.F., Xiang J., Tang C.K. TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. J. Atheroscler. Thromb. 2010, 17:493-502.
14. Han J., Hajjar D.P., Tauras J.M., Feng J., Gotto A.M., Nicholson A.C. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 2000, 275:1241-1246.
15. Pioli P., Goonan K., Wardwell K., Guyre P. TGF-beta regulation of human macrophage scavenger receptor CD163 is Smad3-dependent. J. Leukoc. Biol. 2004, 76:500-508.
16. Irvine S., Foka P., Rogers S., Mead J., Ramji D. A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res. 2005, 33:1423-1434.
17. Bottalico L., Wager R., Agellon L., Assoian R., Tabas I. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 1991, 266:22866-22871.
18. Draude G., Lorenz R. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1042-H1048.
19. Argmann C., Van Den Diepstraten C., Sawyez C., Edwards J., Hegele R., Wolfe B., Huff M. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler. Thromb. Vasc. Biol. 2001, 21:2011-2018.
20. Panousis C., Evans G., Zuckerman S. TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma. J. Lipid Res. 2001, 42:856-863.
21. Salter R.C., Arnaoutakis K., Michael D.R., Singh N.N., Ashlin T.G., Buckley M.L., Kwan A.P., Ramji D.P. The expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the anti-atherogenic cytokine transforming growth factor-β and requires Smads, p38 mitogen-activated protein kinase and c-Jun. Int. J. Biochem. Cell Biol. 2011, 43:805-811.
22. Brown K., Pietenpol J., Moses H. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J. Cell. Biochem. 2007, 101:9-33.
23. Woodward R.N., Finn A.V., Dichek D.A. Identification of intracellular pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells. Atherosclerosis 2006, 186:92-100.
24. Deaton R.A., Su C., Valencia T.G., Grant S.R. Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J. Biol. Chem. 2005, 280:31172-31181.
25. Kalinina N., Agrotis A., Antropova Y., Ilyinskaya O., Smirnov V., Tararak E., Bobik A. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1391-1396.
26. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
27. Moustakas A., Heldin C.H. Non-Smad TGF-beta signals. J. Cell Sci. 2005, 118:3573-3584.
28. Grewal T., Priceputu E., Davignon J., Bernier L. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler. Thromb. Vasc. Biol. 2001, 21:825-831.
29. Chung K., Hart C., Al-Bassam S., Avery A., Taylor J., Patel P., Vojtek A., Turner D. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 2006, 34:e53.
30. Stanton R., McSharry B., Armstrong M., Tomasec P., Wilkinson G. Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques 2008, 45:659-662. (664-658).
31. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 1991, 47:22-31.
32. Izawa D., Pines J. How APC/C-Cdc20 changes its substrate specificity in mitosis. Nat. Cell Biol. 2011, 13:223-233.
33. Chen W.Y., Wang D.H., Yen R.C., Luo J., Gu W., Baylin S.B. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005, 123:437-448.
34. Yang S.H., Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 2004, 13:611-617.
35. Larigauderie G., Furman C., Jaye M., Lasselin C., Copin C., Fruchart J.C., Castro G., Rouis M. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:504-510.
36. Chandok M.R., Okoye F.I., Ndejembi M.P., Farber D.L. A biochemical signature for rapid recall of memory CD4 T cells. J. Immunol. 2007, 179:3689-3698.
37. Geng Y., Hansson G. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 1992, 89:1322-1330.
38. Goldstein J., Ho Y., Basu S., Brown M. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:333-337.
39. Morawietz H., Rueckschloss U., Niemann B., Duerrschmidt N., Galle J., Hakim K., Zerkowski H.R., Sawamura T., Holtz J. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999, 100:899-902.
40. Morawietz H., Duerrschmidt N., Niemann B., Galle J., Sawamura T., Holtz J. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1. Clin. Sci. (Lond.) 2002, 103(Suppl. 48):9S-12S.
41. Jagavelu K., Tietge U.J., Gaestel M., Drexler H., Schieffer B., Bavendiek U. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice. Circ. Res. 2007, 101:1104-1112.
42. Araki N., Johnson M.T., Swanson J.A. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 1996, 135:1249-1260.
43. Corcoran M.P., Lichtenstein A.H., Meydani M., Dillard A., Schaefer E.J., Lamon-Fava S. The effect of 17beta-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu. J. Mol. Endocrinol. 2011, 47:109-117.
44. Libby P., Ridker P., Hansson G. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 2009, 54:2129-2138.
45. Ramji D., Singh N., Foka P., Irvine S., Arnaoutakis K. Transforming growth factor-beta-regulated expression of genes in macrophages implicated in the control of cholesterol homoeostasis. Biochem. Soc. Trans. 2006, 34:1141-1144.
46. Sluijter J., Verloop R., Pulskens W., Velema E., Grimbergen J., Quax P., Goumans M., Pasterkamp G., de Kleijn D. Involvement of furin-like proprotein convertases in the arterial response to injury. Cardiovasc. Res. 2005, 68:136-143.
47. Nachtigal P., Vecerova L., Pospisilova N., Micuda S., Brcakova E., Navarro Hernandez E., Pospechova K., Semecky V. Endoglin co-expression with eNOS, SMAD2 and phosphorylated SMAD2/3 in normocholesterolemic and hypercholesterolemic mice: an immunohistochemical study. Histol. Histopathol. 2009, 24:1499-1506.
48. Bot P., Hoefer I., Sluijter J., van Vliet P., Smits A., Lebrin F., Moll F., de Vries J., Doevendans P., Piek J., Pasterkamp G., Goumans M. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke 2009, 40:439-447.
49. Zheng R., Xiong Q., Zuo B., Jiang S., Li F., Lei M., Deng C., Xiong Y. Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells. Cell Biochem. Funct. 2008, 26:548-556.
50. Dong Y., Tang L., Letterio J., Benveniste E. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J. Immunol. 2001, 167:311-319.
51. Frederick J., Liberati N., Waddell D., Shi Y., Wang X. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 2004, 24:2546-2559.